These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 3137737

  • 21. [Hypophyseal dysfunction and chronic hemodialysis].
    Holzer H, Goebel R, Pogglitsch H, Katschnig H, Leb G.
    Acta Med Austriaca; 1978; 5(3):96-7. PubMed ID: 752223
    [Abstract] [Full Text] [Related]

  • 22. [Effect of mestranol and chlormadinone acetate on HGH secretion in Turner's syndrome].
    Rudolf K, Kunkel S, Woltanski KP.
    Zentralbl Gynakol; 1985; 107(23):1454-9. PubMed ID: 2420102
    [Abstract] [Full Text] [Related]

  • 23. Euprolactinemic Galactorrhea. Response of bioassayable prolactin to thyrotropin-releasing hormone.
    Ataya KM, Subramanian MG, Lawson DM, Gala RR.
    J Reprod Med; 1996 Mar; 41(3):156-60. PubMed ID: 8778412
    [Abstract] [Full Text] [Related]

  • 24. [Theoretical principles and personal experiences in the use of a sequential stimulation test with arginine, gonadotropin-releasing hormone and thyrotropin-releasing hormone in healthy probands].
    Rudolf K, Kunkel S, Rudolf H, Rüting M, Töwe J.
    Zentralbl Gynakol; 1985 Mar; 107(21):1282-95. PubMed ID: 3936306
    [Abstract] [Full Text] [Related]

  • 25. Zinc does not acutely suppress prolactin in normal or hyperprolactinemic women.
    Koppelman MC, Greenwood V, Sohn J, Deuster P.
    J Clin Endocrinol Metab; 1989 Jan; 68(1):215-8. PubMed ID: 2491863
    [Abstract] [Full Text] [Related]

  • 26. Repetitive administration of thyrotropin-releasing hormone results in small elevations of serum thyroid hormones and in marked inhibition of thyrotropin response.
    Snyder PJ, Utiger RD.
    J Clin Invest; 1973 Sep; 52(9):2305-12. PubMed ID: 4199417
    [Abstract] [Full Text] [Related]

  • 27. Serum prolactin levels in patients with fibrocystic breast disease.
    Peters F, Schuth W, Scheurich B, Breckwoldt M.
    Obstet Gynecol; 1984 Sep; 64(3):381-5. PubMed ID: 6431348
    [Abstract] [Full Text] [Related]

  • 28. [Reevaluation of the I-dopa test in acromegaly: anatomo-clinical and prognostic correlations].
    De Marinis L, Mancini A, Zuppi P, Fiumara C, Iacona T, Conte G, Fabrizi ML, Valle D, Anile C, Maira G.
    Minerva Chir; 1993 Nov; 48(21-22):1337-40. PubMed ID: 8152567
    [Abstract] [Full Text] [Related]

  • 29. [Hyperthyroidism and subjects hyperresponding to thyrotropin. Importance of simultaneous thyrotropin and prolactin determination following administration of thyroid-releasing hormone].
    Schlienger JL, De Laharpe F, Reville P, Stephan F.
    Sem Hop; 1993 Nov; 56(17-18):827-31. PubMed ID: 6248964
    [Abstract] [Full Text] [Related]

  • 30. Responsiveness of the pituitary to stimulation with arginine, GRH and TRH in patients with Turner' syndrome (karyotype 45, XO).
    Kunkel S, Rudolf K, Kyank H, Woltanski P, Pelz L.
    Acta Univ Palacki Olomuc Fac Med; 1981 Nov; 101():84-9. PubMed ID: 6211058
    [No Abstract] [Full Text] [Related]

  • 31. Hyperprolactinemia and impaired pituitary response to suppression and stimulation in chronic renal failure: reversal after transplantation.
    Lim VS, Kathpalia SC, Frohman LA.
    J Clin Endocrinol Metab; 1979 Jan; 48(1):101-7. PubMed ID: 106066
    [No Abstract] [Full Text] [Related]

  • 32. Bioactive and immunoactive prolactin levels after TRH-stimulation in the sera of normal women.
    Maddox PR, Jones DL, Mansel RE.
    Horm Metab Res; 1992 Apr; 24(4):181-4. PubMed ID: 1601394
    [Abstract] [Full Text] [Related]

  • 33. Coincidence of gonadal dysgenesis and hyperprolactinemia.
    Rudolf K, Kunkel S.
    Exp Clin Endocrinol; 1988 Mar; 92(3):363-5. PubMed ID: 3150957
    [Abstract] [Full Text] [Related]

  • 34. Effect of psychological stress on human growth hormone response to thyrotropin-releasing hormone in normal controls.
    Tamai H, Esaki M, Takeno K, Matsubayashi S, Nakagawa T, Okimura MC, Walter RM, Kumagai LF.
    Psychother Psychosom; 1986 Mar; 46(3):122-6. PubMed ID: 3114818
    [Abstract] [Full Text] [Related]

  • 35. Hyperprolactinemia in chronic renal failure: impaired responsiveness to stimulation and suppression. Normalization after transplantation.
    Peces R, Horcajada C, López-Novoa JM, Frutos MA, Casado S, Hernando L.
    Nephron; 1981 Mar; 28(1):11-6. PubMed ID: 6791043
    [Abstract] [Full Text] [Related]

  • 36. [Dynamic evaluation of prolactin secretion in acromegaly (author's transl)].
    Chacra AR, Zampieri M, Lengyel AM, Vieira JG.
    Rev Bras Pesqui Med Biol; 1980 Apr; 13(1-3):57-64. PubMed ID: 6774385
    [Abstract] [Full Text] [Related]

  • 37. Prolactin dynamics in a patient with isolated ACTH deficiency accompanied by hyperprolactinemia.
    Shibutani Y.
    Am J Med Sci; 1988 Feb; 295(2):140-3. PubMed ID: 2830786
    [Abstract] [Full Text] [Related]

  • 38. Suppression of serum immunoreactive human epidermal growth factor by acute increase in prolactin in women.
    Chen CF, Kurachi H, Miyake A, Aono T, Tanizawa O.
    Endocrinol Jpn; 1989 Apr; 36(2):203-9. PubMed ID: 2506003
    [Abstract] [Full Text] [Related]

  • 39. Effect of pyridoxine on plasma levels of HGH, PRL, and TSH in normal women.
    Peters F, Zimmermann G, Breckwoldt M.
    Acta Endocrinol (Copenh); 1978 Oct; 89(2):217-20. PubMed ID: 358720
    [Abstract] [Full Text] [Related]

  • 40. [Study of prolactin in the blood in basal conditions and after stimulation with TRH in thyrotoxicosis after administration of reserpine or amitriptyline].
    Conte N, Gasparini G, Manente P, Valmachino G, Gasparoni P, Lo Giudice C, Rota G, Ferlin G.
    Clin Ter; 1978 Jun 15; 85(5):489-95. PubMed ID: 98257
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.